Menu
ETF
Annual · values20252024
Operating Cash Flow-22.86 M USD-20.09 M USD
Depreciation & Amortization216000 USD206000 USD
Stock-Based Compensation826000 USD156000 USD
Capital Expenditures90000 USD153000 USD
Cash Flow from Investing-90000 USD-153000 USD
Cash Flow from Financing23.60 M USD15.07 M USD
Dividends Paid
Stock Buybacks
Free Cash Flow-22.95 M USD-20.24 M USD

CapsoVision, Inc. is a commercial-stage medical technology company specializing in advanced imaging and artificial intelligence technologies for endoscopy solutions. It focuses on identifying abnormalities in the gastrointestinal tract for diagnostic and screening purposes. The company's core product is the CapsoCam Plus, a single-use capsule endoscope system that provides panoramic visualization of the small-bowel mucosa to detect conditions such as obscure gastrointestinal bleeding and Crohn's disease. Additional offerings include CapsoCam Colon for colon visualization, polyp detection, and measurement, along with CapsoCloud, a cloud-based software-as-a-service platform for video access and download; CapsoAccess for capsule data management; CapsoView for video reading; and CapsoRetrieve, a retrieval kit using a magnetic wand. CapsoVision also provides capsule video reading services. These solutions serve gastrointestinal medical practices, clinics, and hospitals through distributor customers who resell the products. Founded in 2005 and headquartered in Saratoga, California, CapsoVision plays a key role in enhancing non-invasive diagnostic capabilities within the health technology sector.